Case Closed? Study Rules Out Mystery Neurologic Syndrome
The study, which was published on May 7 in JAMA Neurology, found 'no support for the existence of an undiagnosed mystery disease' in a cross-section of 222 cases reported to Public Health New Brunswick (PHNB). Instead, the authors suggested that all patients had 'other diagnosable neurological conditions that could benefit from multidisciplinary treatment and other resources.'
'When you start to see the evidence, as we did, you realize that it's a house of cards,' Lang told Medscape Medical News.
'The consequences of this are immense,' he continued. 'Being told you have a mystery disease that could be fatal…a progressive, fatal disease with rapidly progressive dementia, is very harmful…and we really feel that patients who have received this diagnosis need to avail themselves of a proper second opinion by experts and then have the appropriate treatment when it's possible.'
Low Uptake
To be eligible for the study, New Brunswick patients had to have a provisional diagnosis of NSUC, atypical prion disease, neurotoxic syndrome, or rapidly progressive dementia (RPD). Eligible patients were invited to undergo additional testing and clinical evaluation by an independent expert.
But because of the controversy around the issue, which has created political heat and public mistrust since the first cases were reported in 2019, many patients either refused (n = 52) or did not respond (n = 42) to the invitation.
Among 105 patients originally assessed by Alier Marrero, MD, at the Moncton Interdisciplinary Neurodegenerative Diseases (MIND) clinic, Moncton, New Brunswick, which was set up to handle the problem, consent (or waiver of consent) was obtained for only 25 cases: 14 living and 11 deceased.
The median age at symptom onset in the cohort was 55 years, ranging from 16 to 81 years. Data from patients' initial consultations and follow-ups were analyzed along with the results of a second, independent clinical evaluation by a movement disorders specialist or a behavioral neurologist.
Additional testing included electrophysiology evaluation for movement disorders, complete neurocognitive assessment, EEG, Dopamine Transporter Scan, and [18F]fludeoxyglucose–positron emission tomography.
For the deceased patients, autopsies included pathology evaluation as part of the Canadian Creutzfeldt-Jakob Disease Surveillance System with extensive tissue sampling and immunohistochemical analysis for prion diseases and other dementias.
Other Diagnoses
All 25 patients had 'definable and diagnosable neurological disorders that really refuted the concept of a mysterious brain disease of unknown cause or an NSIC,' said Lang. Diagnoses included Alzheimer's disease, Parkinson's disease, progressive supranuclear palsy, other neurodegenerative conditions, functional neurologic disorder, traumatic brain injury, and persisting postconcussion symptoms, he said.
'Diagnostic inaccuracies stemmed from incorrect interpretation of histories (eg, overdiagnosis of RPD), inaccurate physical examination interpretation (eg, myoclonus, ataxia), and overreliance on or misinterpretation of ancillary testing such as EEG and SPECT [single-photon emission computed tomography],' wrote the study authors.
'The records were not accurate,' said Lang. 'They said the patient had hallucinations, or the patient had such and such. When we asked the patient who came back for a second opinion, they said, 'No, I never had that.' Or there was documentation of myoclonus, of ataxia, of dementia, and then we found no myoclonus, no ataxia, no dementia on clinical examination.'
The researchers also used statistical modeling to calculate the probability of NSUC in the other cases not included in the study. 'We said, well, what about the other 200-some patients that had been documented in public health? What are the chances of any of them having a mysterious, undiagnosed neurological disease? And the statistics said that it was less than a one-in-a-million chance of any of those remaining patients having a mystery disease,' he said. 'So, we feel very confident that even though we have the small numbers, they are very, very convincing.'
But Marrero disputed the JAMA findings. He first raised concerns with provincial health authorities in 2020 about a growing number of atypical RPD cases in the province, including several cases of Creutzfeldt-Jakob disease.
Marrero was initially hired as one of the clinicians who followed the patients at MIND but was fired in 2022 for performance reasons and moved to the Dr Georges-L.-Dumont University Hospital Centre in Moncton. His patients were given the option to follow him or be assigned a new MIND clinician.
An initial public health review and separate epidemiologic investigation of the first 48 cases concluded that the patients shared no common symptoms or syndrome. 'Although some of the cases have presentations with unusual symptomology, they do not appear to have a common illness with an unknown etiology, and there is no evidence of a cluster of a neurological syndrome of unknown cause,' it concluded, according to a provincial government website established to update the public.
The investigation was closed, but after a provincial election in October 2024, the newly elected government reopened the investigation. Although public health authorities have officially recorded 222 cases, Marrero, who was disciplined for improper paperwork and reporting, told Medscape Medical News that he has now evaluated more than 500 patients in this cluster.
'I am appalled that a parallel investigation with a small number of patients has apparently been conducted for a long time without our knowledge or our patients' and families' knowledge,' he said. 'I am in profound disagreement with the study conclusions and have many questions regarding the methods and the content.'
Not Convinced
New Brunswick's Chief Medical Officer of Health, Yves Leger, MD, emphasized in a statement that the JAMA findings 'do not change my office's intention to complete its own investigation into cases of undiagnosed neurological illness in New Brunswick. Work has been underway on this matter since early 2023 with support from the Public Health Agency of Canada (PHAC).'
'There are too many unanswered questions for us to stop the work that Public Health is doing to be able to provide patients — and potentially future patients — with the information they need about what's causing these illnesses,' New Brunswick Premier Susan Holt told reporters in reaction to the JAMA findings.
'On request from PHNB, PHAC has also agreed to conduct a scientific review of the investigation findings once PHNB has completed its analysis and interpretation,' said a spokesperson for PHAC.
'I trust that the current process of independent multidisciplinary scientific investigation and extensive file analysis that is underway by our public health authorities could provide appropriate answers to our communities,' said Marrero. 'We are hopeful that this process would include not only comprehensive additional patient testing but also testing for water, food, soil, and air samples in the affected areas, as well as additional patient support and effective prevention and treatment measures.'
But Connie Marras, MD, PhD, a University of Toronto neurologist and movement disorder specialist with an expertise in epidemiology, questioned the need for further investigation.
'It is premature to start looking at any environmental agents that might be responsible for this before we have evidence that there is indeed a cluster, and both the investigations that have been done so far don't support that,' Marras, who was not involved in any of the investigations, told Medscape Medical News. 'The evidence that has been pulled together to date strongly suggests that there is not a unifying, underlying diagnosis for these individuals.'
If the current evidence is insufficient to convince public health and the public, then an ideal next step, from an epidemiologic point of view, would be to test a larger, random sample of patients, she said. The limitations of the JAMA study included small numbers and the potential for selection bias.
'If the purportedly affected people are willing to submit to further evaluation, their engagement in this is critical, for the sake of everybody.'
The study 'underscores the critical importance of systematic data collection and objective evaluation (seeing) in cases of neurological syndromes with unknown causes,' wrote Michael Okun, MD, professor of neurology and director of the Norman Fixel Institute for Neurological Diseases at the University of Florida Health in Gainesville, Florida, in a post on X.
'I completely agree with the authors that these types of unknown 'neuro' cases are 'complex neurological disorders [that will] benefit from a second, independent and/or subspecialist evaluation and require multidisciplinary support throughout the diagnostic journey.' Always ask yourself, 'Do you see what you want to see? Are you being rigorous and as unbiased as possible? Are you open to revising your initial impressions? Can a second look enhance diagnostic accuracy and outcomes?'…These authors are sharing hard data to help us to understand a phenomenon. We must always seek clarity.'
No funding source for the study was reported. Lang reported receiving personal fees from AbbVie, AFFiRis, Alector, Amylyx Pharmaceuticals, APRINOIA Therapeutics, Biogen, BioAdvance, Biohaven, BioVie, BlueRock, Bristol Myers Squibb, Cavion, CoA Therapeutics, Denali, Janssen Pharmaceuticals, Jazz Pharmaceuticals, Lilly, Novartis, Paladin, Pharma Two B Ltd., PsychoGenics, Roche, Sun Pharma, and UCB outside the submitted work and litigation related to paraquat and Parkinson's disease (for the plaintiffs). Marrero and Marras reported having no relevant financial relationships.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Post
10 hours ago
- New York Post
Grow up in the ‘60s or ‘70s? This ‘dangerously high' exposure may have put your brain at risk
Prepare to fume. Leaded gasoline was widely used as car fuel in the US from the 1920s until the 1970s — it was phased out because it was found to be harmful to the environment and human health. It's taken decades for the extent of lead's toxicity to be fully understood. A new study adds to the grim news — if you lived in an area with high levels of atmospheric lead between 1960 and 1974, when leaded gas was at its peak, you're 20% more likely to suffer memory problems later in life. 4 This photo shows cars lining up at a California gas station on Sep. 21, 1973, during peak use of leaded fuel. AP 'Research suggests half the US population — more than 170 million people — were exposed to high lead levels in early childhood,' said Maria C. Carrillo, the Alzheimer's Association's chief science officer and medical affairs lead. 'This research sheds more light on the toxicity of lead related to brain health in older adults today.' Lead was initially added to gas in the early 1920s to improve engine performance and prevent a knocking or rattling sound that occurs when fuel burns unevenly in the engine's cylinders. It was eventually deemed dangerous to the maturing brains and nervous systems of young children, who experienced developmental, learning and behavioral difficulties. 4 Leaded gas was slowly phased out in the US for on-road vehicles before being banned in 1996. This photo is of an NYC gas station circa 1980. Getty Images Adults faced neurological and reproductive issues, and soil and water contamination persisted. The sale of leaded fuel for on-road vehicles was gradually reduced in the US over two decades, with a full ban taking effect in 1996. For the new study, University of Toronto researchers mapped historic atmospheric lead levels in the US. They compared this data to the memory difficulties that more than 600,000 residents 65 and over described from 2012 to 2021. Residents were only included in the analysis if they lived in their birth state. The study authors calculated that 17% to 22% of people in places with moderate, high or extremely high atmospheric lead levels reported memory problems. 'When I was a child in 1976, our blood carried 15 times more lead than children's blood today,' said Esme Fuller-Thomson, senior author of the study and director of the Institute for Life Course and Aging at the University of Toronto. 'An astonishing 88% of us had levels higher than 10 micrograms per deciliter, which are now considered dangerously high.' 4 A new study suggests that if you lived in an area with high levels of atmospheric lead between 1960 and 1974, when leaded gas was at its peak, you're 20% more likely to suffer memory problems later in life. wirojsid – The researchers — who are presenting their work this week at the Alzheimer's Association International Conference (AAIC) in Toronto — recommend that those concerned about decades-old lead exposure focus on reducing other dementia risk factors, such as high blood pressure, smoking and loneliness. Over 6 million Americans have dementia, which gradually destroys memory, concentration and judgment skills. It's responsible for more than 100,000 deaths each year. Unfortunately, there's no easy way to measure long-term lead exposure. Lead levels in the blood primarily reflect recent or ongoing exposure. Lead is stored in the bones for significantly longer than in the blood — but that marker presents challenges. 'Some research studies have measured lead in the bone,' Dr. Eric Brown, lead study author, told The Post. 'This is done by using a technology called K-X-ray fluorescence, however, it is not available to the general public and is primarily a research tool, not a clinical tool.' What's more, leaded gas is still used in some aircraft and race cars — and lead pipes and paint remain a significant public health concern in many areas. 4 This photo from June 2020 shows lead paint chipping off a wall in Clifton, NJ. Christopher Sadowski A separate study shared at AAIC revealed that lead exposure — even at low levels — can contribute to the accumulation of abnormal tau and amyloid beta, proteins associated with Alzheimer's disease, in brain cells. And finally, another AAIC study found that older adults living about 3 miles from a lead-releasing facility — such as glass, ready-mixed concrete or computer and electronics manufacturers — face greater odds of memory and thinking problems than those living farther away. 'Our results indicate that lead exposure in adulthood could contribute to worse cognitive performance within a few years,' said Kathryn Conlon, senior study author and an associate professor of environmental epidemiology at UC Davis. 'Despite tremendous progress on lead abatement,' she added, 'studies have shown there is no safe level of exposure, and half of US children have detectable levels of lead in their blood.'
New York Post
a day ago
- New York Post
New York hit with air quality alert as Canadian wildfire smoke spreads
New York was hit with an air quality alert Saturday as smoke from Canadian wildfires drifted across the state. The warning, issued by the state's Department of Environmental Conservation and the Department of Health, covers the five boroughs, Long Island, the Lower and Upper Hudson Valley and the Adirondacks. 3 Hazy skies blanketed New York on Saturday as wildfire smoke from Canada triggered an air quality alert across the state. Ron Adar / M10s / Advertisement Officials advised New Yorkers to stay indoors and skip strenuous outdoor activity. Pollution from fine particulate matter — PM2.5 — is expected to push the Air Quality Index over 100, hitting levels considered unhealthy for sensitive groups, including children, older adults and people with heart or lung conditions. 3 Officials warned vulnerable New Yorkers to stay indoors as fine particle pollution reached unhealthy levels. Getty Images Advertisement The tiny particles can cause eye, nose and throat irritation, along with coughing, sneezing and shortness of breath. They can also worsen asthma and heart disease. The alert is expected to remain in effect until Sunday. It's the latest smoke surge to cloud city skies this year. An alert was also issued in early June, when ozone pollution and wildfire haze from Canada triggered warnings across the tri-state. Advertisement 3 Smoke from hundreds of Canadian wildfires drifted south, clouding skies from the Adirondacks to the Big Apple. Robert Sabo for NY Post As of July 23, Canada has seen 3,345 fires in 2025 — scorching over 14 million acres, more than double the 10-year average. More than 50 remain out of control.
USA Today
a day ago
- USA Today
Smoke descends on Northeastern US. Map shows air quality impacts.
State officials from Maine to New York issued alerts for fine particulate matter, a toxic byproduct of wildfires that is small enough to be inhaled. NEW YORK − Wildfire smoke wafted from Canada to create unhealthy air quality levels across the Northeast on July 26. State officials from Maine to New York issued alerts for fine particulate matter, a toxic byproduct of wildfires that is small enough to be inhaled. Smoky conditions impacted cities including Boston and New York. Canada's fires could produce more smoke blowing into the Northeast through the afternoon, said Brooke Taber, a National Weather Service meteorologist stationed in Burlington, Vermont. Smoke is also causing limited visibility in some areas. Wind changes could provide a respite by the night, Taber said. Montreal had some of the worst air quality in the world due to fires in the Canadian Prairies, the Canadian Press reported, citing IQAir, a Swiss-based monitoring company. Several wildfires burning in Saskatchewan and Manitoba are sending large smoke plumes eastward, according to Quebec's fire provincial agency. Meanwhile, New York City climbed on IQAir's list of cities with unhealthy air levels. Hazy skies and the faint smell of smoke blanketed Manhattan on Saturday. Map shows US air quality Why air quality matters Officials urged people to stay indoors to reduce exposure, and to limit strenuous activity. Exposure can cause short-term effects such as irritation of the eyes, nose and throat, along with coughing, sneezing, runny nose and shortness of breath. It can be particularly dangerous for people in sensitive groups, such as children, older people and those with chronic health conditions, such as asthma or heart disease. Canada is experiencing another harsh wildfire season in a warming climate. Dozens of wildfires are blazing uncontrolled, according to Canada's natural resources department. In early July, Manitoba's government declared a state of emergency for its historic fires. July 17: Brace for more smoky skies as Canadian wildfires rage Eduardo Cuevas is based in New York City. Reach him by email at emcuevas1@ or on Signal at emcuevas.01.
